These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35645542)

  • 41. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching.
    Kaltenbach TR; Soetikno RM; DeVivo R; Laine LA; Barkun A; McQuaid KR;
    Gastrointest Endosc; 2017 Dec; 86(6):1107-1117.e1. PubMed ID: 28818507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act".
    Sheridan TB; Fenton H; Lewin MR; Burkart AL; Iacobuzio-Donahue CA; Frankel WL; Montgomery E
    Am J Clin Pathol; 2006 Oct; 126(4):564-71. PubMed ID: 16938659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flat serrated adenomas of the colorectal mucosa in Japanese patients.
    Rubio CA; Kato Y; Hirota T; Muto T
    In Vivo; 1996; 10(3):339-43. PubMed ID: 8797037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colorectal Cancer Screening for the Serrated Pathway.
    Anderson JC; Srivastava A
    Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):457-478. PubMed ID: 32439082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease.
    Rubio CA; Befrits R; Jaramillo E; Nesi G; Amorosi A
    Anticancer Res; 2000; 20(6C):4761-4. PubMed ID: 11205214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serrated Lesions in Inflammatory Bowel Disease: Genotype-Phenotype Correlation.
    Brcic I; Dawson H; Gröchenig HP; Högenauer C; Kashofer K
    Int J Surg Pathol; 2021 Feb; 29(1):46-53. PubMed ID: 33030071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
    Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
    Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA Signatures of Colonic Polyps on Screening and Histology.
    Tsikitis VL; Potter A; Mori M; Buckmeier JA; Preece CR; Harrington CA; Bartley AN; Bhattacharyya AK; Hamilton SR; Lance MP; Thompson PA
    Cancer Prev Res (Phila); 2016 Dec; 9(12):942-949. PubMed ID: 27658891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
    Lv C; Zhao X; Gu H; Huang L; Zhou S; Zhi F
    Med Sci Monit; 2016 Dec; 22():4794-4802. PubMed ID: 27926694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The frequency of early colorectal cancer derived from sessile serrated adenoma/polyps among 1858 serrated polyps from a single institution.
    Chino A; Yamamoto N; Kato Y; Morishige K; Ishikawa H; Kishihara T; Fujisaki J; Ishikawa Y; Tamegai Y; Igarashi M
    Int J Colorectal Dis; 2016 Feb; 31(2):343-9. PubMed ID: 26510850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colorectal polyps: Targets for fluorescence-guided endoscopy to detect high-grade dysplasia and T1 colorectal cancer.
    Dekkers N; Zonoobi E; Dang H; Warmerdam MI; Crobach S; Langers AMJ; van der Kraan J; Hilling DE; Peeters KCMJ; Holman FA; Vahrmeijer AL; Sier CFM; Hardwick JCH; Boonstra JJ
    United European Gastroenterol J; 2023 Apr; 11(3):282-292. PubMed ID: 36931635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the pathologic and endoscopic measurements of colorectal polyp sizes with a focus on sessile serrated adenoma and high-grade dysplasia.
    Li F; Chen Z; Yang Y; Yi X; Yang Y; Zhang L
    Int J Clin Exp Pathol; 2014; 7(4):1635-43. PubMed ID: 24817960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
    J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colorectal dysplasia in chronic inflammatory bowel disease: a contemporary consensus classification and interobserver study.
    Harpaz N; Goldblum JR; Shepherd NA; Riddell RH; Rubio CA; Vieth M; Wang HH; Odze RD
    Hum Pathol; 2023 Aug; 138():49-61. PubMed ID: 37247824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal Cancers.
    Din S; Wong K; Mueller MF; Oniscu A; Hewinson J; Black CJ; Miller ML; Jiménez-Sánchez A; Rabbie R; Rashid M; Satsangi J; Adams DJ; Arends MJ
    Clin Cancer Res; 2018 Oct; 24(20):5133-5142. PubMed ID: 29950348
    [No Abstract]   [Full Text] [Related]  

  • 59. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
    Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
    Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.
    Choi CH; Ignjatovic-Wilson A; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Rutter MD; Graham TA; Hart AL
    Am J Gastroenterol; 2015 Oct; 110(10):1461-71; quiz 1472. PubMed ID: 26416190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.